Recent Updates

Published: 
Mar 31, 2017
Chapter 7

Background

Originally all plasma fractionation products were derived from pooled human plasma. Increasingly, many plasma proteins are manufactured by biotechnology as recombinant proteins, without need of donated plasma; depending on the particular plasma protein product, a recombinant or a fractionated product or both are available in Canada.

This Chapter presents in general terms the various methods and principles by which plasma protein products are manufactured for use in patients. It is complemented by Chapter 3, 4, 5 and 6 of this Guide.

Transfusion
Published: 
Sep 8, 2017
Chapter 2

This chapter describes the manufacturing process for the most commonly prepared blood products: Red Blood Cells, Pooled Platelets, Frozen Plasma (FP), Apheresis Fresh Frozen Plasma (AFFP), Cryosupernatant Plasma (CSP) and Cryoprecipitate. A brief description of the indications, contraindications, storage and transportation requirements, dose, administration and available alternatives is included in the sections below. Further information may be found in other chapters of this Guide as indicated within the different sections.

Transfusion
Published: 
Jan 17, 2019
Chapter 1

This first chapter of the Clinical Guide to Transfusion provides an overview of the blood system in Canada, the regulations and standards that are in place and the organizations and professionals that, together, ensure transfusion medicine safety for Canadian patients. 

Transfusion

Upcoming Events

When
January 24, 2019 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Speaker

Dr. Tanya Petrasko, MD, FRCPC
Associate Medical Director, West 
Medical Director, Cord Blood Bank
Canadian Blood Services

Transfusion
When
February 5, 2019 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Speaker:

Dr. Lani Lieberman, MD, FRCPC
Assistant Professor, Transfusion Laboratory, University of Toronto

More details to follow.

 

Transfusion

Blog

Modified on: 
Jan 14, 2019

Five hundred kidney transplants made possible through national highly sensitized patient program

Modified on: 
Jan 9, 2019

#WeDoResearch! Through our Centre for Innovation, our engaged network of scientists, medical experts, partners, and collaborators conduct and disseminate high quality, impactful research for the benefit of Canadian patients and the Canadian healthcare system.   

Modified on: 
Dec 31, 2018

As the year comes to a close and 2019 is set to begin, we take a moment to reflect on the 2018 articles that were among the most popular.